| pubmed-article:11216968 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0948089 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0253563 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C1540850 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0020003 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0587437 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:11216968 | lifeskim:mentions | umls-concept:C0809949 | lld:lifeskim |
| pubmed-article:11216968 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11216968 | pubmed:dateCreated | 2001-2-16 | lld:pubmed |
| pubmed-article:11216968 | pubmed:abstractText | We aimed to evaluate the benefits of the glycoprotein (GP) IIb/IIIa antagonist, eptifibatide, after patients with acute coronary syndromes (ACS) were admitted to hospitals that approach revascularization for ACS through early transfer to tertiary referral centers. | lld:pubmed |
| pubmed-article:11216968 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11216968 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11216968 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11216968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11216968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11216968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11216968 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11216968 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11216968 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:WilcoxR GRG | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:SimoonsM LML | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:CaliffR MRM | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:CokkinosD VDV | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:OhmanE MEM | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:TopolE JEJ | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:GuerciAA | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:KatzE SES | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:LincoffA MAM | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:HudsonM PMP | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:HarringtonR... | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:BerdanL GLG | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:GreenbaumA... | lld:pubmed |
| pubmed-article:11216968 | pubmed:author | pubmed-author:MacAulayC MCM | lld:pubmed |
| pubmed-article:11216968 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11216968 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:11216968 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11216968 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11216968 | pubmed:pagination | 492-8 | lld:pubmed |
| pubmed-article:11216968 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:meshHeading | pubmed-meshheading:11216968... | lld:pubmed |
| pubmed-article:11216968 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11216968 | pubmed:articleTitle | Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. | lld:pubmed |
| pubmed-article:11216968 | pubmed:affiliation | Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA. agreenb1@hfhs.org | lld:pubmed |
| pubmed-article:11216968 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11216968 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11216968 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11216968 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
